Ube, Japan

Shigeyoshi Nishino

This inventor holds 29 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Organic Chemistry. Top assignees: Ube Industries, Inc., Astra Zeneca U.k. Limited, Sankyo Company, Limited. Active years: 1994-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeyoshi Nishino. Retrieved from https://idiyas.com/inventor/shigeyoshi-nishino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 

% Patents Active = 24.1

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 73(Granted Patents)


Location History:

  • Yamaguchi, JP (2000 - 2013)
  • Ube, JP (1994 - 2017)

Company Filing History:


Years Active: 1994-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Quinazoline Derivatives
Dibenzothiazepine Compounds
Photoelectric Conversion
Pentafluorosulfanylbenzene
Imidazolidinone Compounds
Tetrahydropyran Compounds
Acylimidazole Compounds
Nitrile Compounds
Carboxylic Acid Esters
Fluorooxindole
Quinolylacrylonitrile
Thienopyridine Derivatives
29 patents (USPTO):Explore Patents

Title: Shigeyoshi Nishino: Innovator in Pharmaceutical and Photovoltaic Technologies

Introduction

Shigeyoshi Nishino, an accomplished inventor based in Ube, Japan, has made significant contributions to the fields of pharmaceuticals and renewable energy technologies. With a remarkable portfolio of 29 patents, his work reflects a deep commitment to innovation and practical solutions in science and technology.

Latest Patents

Nishino's latest patents include an aryloyl(oxy or amino)pentafluorosulfanylbenzene compound, which showcases potential pharmacological action. This compound is represented by a general formula, introducing a pharmaceutically acceptable salt and prodrugs that hold promise for therapeutic applications. Additionally, he has developed a photoelectric conversion element that utilizes a binuclear ruthenium complex dye. This innovative dye features a substituted bipyridyl group and is designed to enhance the absorption of light in the longer wavelength range, thus improving the efficiency of solar energy conversion into electricity.

Career Highlights

Throughout his career, Shigeyoshi Nishino has worked with notable companies, including Ube Industries, Inc. and AstraZeneca UK Limited. His collaborations have positioned him at the forefront of research and development, enabling him to focus on ground-breaking innovations that address real-world problems.

Collaborations

Nishino has collaborated with several esteemed colleagues, including Hidetaka Shima and Kenji Hirotsu, further enriching the collaborative environment of his research efforts. These partnerships have enhanced the scope of his work and facilitated the development of impactful technologies.

Conclusion

Shigeyoshi Nishino stands out as a prolific inventor whose work spans critical domains such as pharmaceuticals and renewable energy. His 29 patents exemplify a dedication to advancing technology and improving human health and sustainability. As industries continue to evolve, Nishino’s innovations are likely to play a vital role in shaping future breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…